Physician profile
Victor Gonzalez
NPI 1790896926
$5,170.24
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,292 · 2020: $801 · 2021: $515 · 2022: $363 · 2023: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,007.63 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $657.75 | 2019-2021 | |
| Allergan, INC. | $556.78 | 2019-2020 | |
| Baxter Healthcare | $450.00 | 2019 | |
| Endo Pharmaceuticals INC. | $274.24 | 2019-2021 | |
| Davol INC. | $238.30 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $152.00 | 2022-2023 | |
| Ethicon US, LLC | $137.17 | 2021 | |
| Acell, INC. | $120.18 | 2019 | |
| Novo Nordisk INC | $110.48 | 2023 | |
| Janssen Pharmaceuticals, INC | $103.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $100.47 | 2021 | |
| Medtronic, INC. | $88.21 | 2021-2022 | |
| Baudax Bio INC. | $86.49 | 2020-2021 | |
| Heron Therapeutics, INC. | $30.13 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $14.63 | 2021 | |
| Tactile Systems Technology INC | $14.16 | 2020 | |
| Covidien LP | $14.03 | 2020 | |
| Integra Lifesciences Corporation | $13.68 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.